Biblio Discovery — Demo Discovery Service

3 results for "Laura M. Spring"

Showing 1–3 · 0.25 seconds · RSS

  1. Journal Article Full text

    ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer

    Jamie O. Brett; Laura M. Spring; Aditya Bardia et al.

    Breast Cancer Research · 2021 · English · OpenAlex Scopus

    In metastatic hormone receptor-positive breast cancer, ESR1 mutations are a common cause of acquired resistance to the backbone of therapy, estrogen deprivation by aromatase inhibition. How these mutations affect tumor sensitivity to established and novel therapies are active areas of research…

  2. Journal Article

    Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis

    Laura M. Spring; Geoffrey G. Fell; Andrea Arfè et al.

    Clinical Cancer Research · 2020 · English · OpenAlex Scopus

    Abstract Purpose: While various studies have highlighted the prognostic significance of pathologic complete response (pCR) after neoadjuvant chemotherapy (NAT), the impact of additional adjuvant therapy after pCR is not known. Experimental Design: PubMed was searched for studies with NAT for breast…

  3. Journal Article Full text

    Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab

    Otto Metzger; Giuseppe Viale; Shayna R. Stein et al.

    Cancer Discovery · 2021 · English · OpenAlex Scopus

    Abstract Intratumor heterogeneity is postulated to cause therapeutic resistance. To prospectively assess the impact of HER2 (ERBB2) heterogeneity on response to HER2-targeted therapy, we treated 164 patients with centrally confirmed HER2-positive early-stage breast cancer with neoadjuvant…